Targeting MAPK4 emerges as a promising therapy for prostate cancer

(Baylor College of Medicine) New research opens the possibility that targeting the enzyme MAPK4 in human prostate cancer might provide a novel therapeutic strategy for this disease that is the second leading cause of cancer death in American men.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news